(S)-3-Amino-3-Phenylpropanoic Acid CAS 40856-44-8 Purity ≥99.0% e.e ≥99.5% Dapoxetine Hydrochloride Intermediate Factory

Short Description:

Chemical Name: (S)-3-Amino-3-Phenylpropanoic Acid

Synonyms: (S)-β-Phenylalanine 

CAS: 40856-44-8

Appearance: White Crystalline Powder

Purity: ≥99.0% e.e: ≥99.5%

Intermediate of Dapoxetine Hydrochloride (CAS: 129938-20-1) in the treatment of Premature Ejaculation in Men (PE) 

Enquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name (S)-3-Amino-3-Phenylpropanoic Acid
Synonyms (S)-β-Phenylalanine; (S)-3-Amino-3-Phenylpropionic Acid; H-(S)-beta-Phe-OH; L-β-Phe-OH; H-β-Phe-OH
CAS Number 40856-44-8
CAT Number RF-CC113
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C9H11NO2
Molecular Weight 165.19
Density 1.198
Melting Point 216.0~224.0°C
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance White Crystalline Powder 
Purity ≥99.0%
e.e ≥99.5%
Specific Rotation [α]D20 -7.0°~ -9.0°(C=0.3, H2O)
Loss on Drying ≤0.20%
Residue on Ignition ≤0.20%
Single Impurity ≤0.50%
Total Impurities ≤1.0%
Non-Animal Origin Non-Animal Origin
Test Standard Enterprise Standard
Usage Chiral Compounds; Pharmaceutical Intermediates

Package & Storage:

Package: Bottle, Cardboard Drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

1

FAQ:

2

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-3-Amino-3-Phenylpropanoic Acid (CAS: 40856-44-8) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis. 

(S)-3-Amino-3-Phenylpropanoic Acid (CAS: 40856-44-8) can be used in the synthesis of Dapoxetine Hydrochloride (CAS: 129938-20-1). Dapoxetine Hydrochloride (CAS: 129938-20-1) is a short-acting novel selective serotonin reuptake inhibitor marketed for the treatment of premature ejaculation in men. Premature ejaculation (PE) is the most common male sexual disorder. 

  • Write your message here and send it to us